Cargando…
Feasibility Study of Mesoporous Silica Particles for Pulmonary Drug Delivery: Therapeutic Treatment with Dexamethasone in a Mouse Model of Airway Inflammation
Diseases in the respiratory tract rank among the leading causes of death in the world, and thus novel and optimized treatments are needed. The lungs offer a large surface for drug absorption, and the inhalation of aerosolized drugs are a well-established therapeutic modality for local treatment of l...
Autores principales: | Gulin-Sarfraz, Tina, Jonasson, Sofia, Wigenstam, Elisabeth, von Haartman, Eva, Bucht, Anders, Rosenholm, Jessica M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523761/ https://www.ncbi.nlm.nih.gov/pubmed/30939753 http://dx.doi.org/10.3390/pharmaceutics11040149 |
Ejemplares similares
-
Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery
por: Prabhakar, Neeraj, et al.
Publicado: (2016) -
Controlled Release of Volatile Antimicrobial Compounds from Mesoporous Silica Nanocarriers for Active Food Packaging Applications
por: Gulin-Sarfraz, Tina, et al.
Publicado: (2022) -
Size, Stability, and Porosity of Mesoporous Nanoparticles Characterized with Light Scattering
por: Kaasalainen, Martti, et al.
Publicado: (2017) -
Characterization of modified mesoporous silica nanoparticles as vectors for siRNA delivery
por: Slita, Anna, et al.
Publicado: (2018) -
Feasibility Study of the Permeability and Uptake of Mesoporous Silica Nanoparticles across the Blood-Brain Barrier
por: Baghirov, Habib, et al.
Publicado: (2016)